[1] Waxman E A, Giasson B I. Molecular mechanisms of alpha-synuclein neurodegeneration[J]. Biochim Biophys Acta, 2009, 1792(7):616-624.[2] Bodhicharla R, Nagarajan A, Winter J, et al. Effects of alpha-synuclein overexpression in transgenic Caenorhabditis elegans strains[J]. CNS Neurol Disord Drug Targets, 2012, 11(8):965-975.[3] Yang W, Wang X, Duan C, et al. Alpha-synuclein overexpression increases phospho-protein phosphatase 2A levels via formation of calmodulin/Src complex[J]. Neurochem Int, 2013, 63(3):180-194.[4] Los G V, Wood K. The HaloTag: a novel technology for cell imaging and protein analysis[J]. Methods Mol Biol, 2007, 356:195-208.[5] Yang F, Yang Y P, Mao C J, et al. Role of autophagy and proteasome degradation pathways in apoptosis of PC12 cells overexpressing human alpha-synuclein[J]. Neurosci Lett, 2009, 454(3):203-208.[6] Silva B A, Breydo L, Uversky V N. Targeting the chameleon: a focused look at alpha-synuclein and its roles in neurodegeneration[J]. Mol Neurobiol, 2013, 47(2):446-459.[7] Witt S N. Molecular chaperones, alpha-synuclein, and neurodegeneration[J]. Mol Neurobiol, 2013, 47(2):552-560.[8] Aarsland D, Kurz M W. The epidemiology of dementia associated with Parkinson disease[J]. J Neurol Sci, 2010, 289(1-2):18-22.[9] Hall H, Jewett M, Landeck N, et al. Characterization of cognitive deficits in rats overexpressing human alpha-synuclein in the ventral tegmental area and medial septum using recombinant adeno-associated viral vectors[J]. PLoS One, 2013, 8(5):e64844.[10] 安子薇, 李建民, 吴庆文, 等.帕金森病康复治疗研究新进展[J].中国煤炭工业医学杂志, 2013, 16(5):851-853.[11] 尹维民.神经内科学发展现状和展望[J].解放军医药杂志, 2013, 22(4):6-9.[12] Hansen C, Bjorklund T, Petit G H, et al. A novel alpha-synuclein-GFP mouse model displays progressive motor impairment, olfactory dysfunction and accumulation of alpha-synuclein-GFP[J]. Neurobiol Dis, 2013, 56:145-155.[13] Recasens A, Dehay B, Bove J, et al. Lewy body extracts from Parkinson' s disease brains trigger alpha-synuclein pathology and neurodegeneration in mice and monkeys[J]. Ann Neurol, 2014, 75(3):351-362.[14] Chumanov R S, Kuhn P A, Xu W, et al. Expression and purification of full-length mouse CARM1 from transiently transfected HEK293T cells using HaloTag technology[J]. Protein Expr Purif, 2011, 76(2):145-153.[15] Encell L P, Friedman Ohana R, Zimmerman K, et al. Development of a dehalogenase-based protein fusion tag capable of rapid, selective and covalent attachment to customizable ligands[J]. Curr Chem Genomics, 2012, 6:55-71.[16] Kovalenko E I, Ranjbar S, Jasenosky L D, et al. The use of HaloTag-based technology in flow and laser scanning cytometry analysis of live and fixed cells[J]. BMC Res Notes, 2011, 4:340.[17] Song J X, Lu J H, Liu L F, et al. HMGB1 is involved in autophagy inhibition caused by SNCA/alpha-synuclein overexpression: A process modulated by the natural autophagy inducer corynoxine B[J]. Autophagy, 2014, 10(1):144-154.[18] Los G V, Encell L P, McDougall M G, et al. HaloTag: A novel protein labeling technology for cell imaging and protein analysis[J]. ACS Chem Biol, 2008, 3(6):373-382.[19] Urh M, Rosenberg M. HaloTag, a platform Technology for Protein Analysis[J]. Curr Chem Genomics, 2012, 6:72-78.[20] Tseng J C, Benink H A, McDougall M G, et al. In Vivo Fluorescent Labeling of Tumor Cells with the HaloTag(R) Technology[J]. Curr Chem Genomics, 2012, 6:48-54.[21] Martincova E, Voleman L, Najdrova V, et al. Live imaging of mitosomes and hydrogenosomes by HaloTag technology[J]. Plos One, 2012, 7(4):e36314.[22] N Peterson S, Kwon K. The HaloTag: improving soluble expression and applications in protein functional analysis[J]. Curr Chem Genomics, 2012, 6:8-17. |